Stomal recurrence following total laryngectomy: Clinical and molecular analysis of a series

Annals of Otology, Rhinology and Laryngology

Volumn 112, Issue 7, 2003, Pages 594-599

  Santoro, Roberto ^a   Franchi, Alessandro ^a   Tempesti, Claudia ^a   Sardi, Iacopo ^a   Polli, Gianni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Laryngeal cancer; Microsatellite analysis; Second primary tumor; Stomal recurrence; Total laryngectomy

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGLOTTIS; EPIGLOTTIS CANCER; GENETIC CORRELATION; GENETIC LINKAGE; GLOTTIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LARYNX CARCINOMA; MALE; MICROSATELLITE INSTABILITY; MORBIDITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TRACHEOTOMY;

EID: 0038164980     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940311200704     Document Type: Article

References (42)

1. Leòn X, Quer M, Burguès J, Abellò P, Vega M, de Andrès L. Prevention of stomal recurrence. Head Neck 1996;18:54-9.
2. Kiem WF, Shapiro MJ, Rosin HD. Study of postlaryngectomy stoma recurrence. Arch Otolaryngol 1965;81:183-6.
3. De Jong PC. Intubation and tumor implantation in laryngeal carcinoma. Pract Otorhinolaryngol 1969;31:1119-21.
4. Batsakis JG, Hybels R, Rice DH. Laryngeal carcinoma: stomal recurrences and distant metastases. Centennial Conference on Laryngeal Cancer, Toronto. New York, NY: Appleton-Century-Crofts, 1974:868-76.
5. Bonneau RA, Lehman RH. Stomal recurrence following laryngectomy. Arch Otolaryngol 1975;101:408-12.
6. Weber RS, Marvel J, Smith P, Hankins P, Wolf P, Goepfert H. Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus. Otolaryngol Head Neck Surg 1993;108:11-7.
7. Harrison DFN. The pathology and management of subglottic cancer. Ann Otol Rhinol Laryngol 1971;80:6-12.
8. Rubin J, Johnson JT, Myers EN. Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 1990;103:805-12.
9. Breneman JC, Bradshaw A, Gluckman J, Aron BS. Prevention of stomal recurrence in patients requiring emergency tracheostomy for advanced laryngeal and pharyngeal tumors. Cancer 1988;62:802-5.
10. Hosal IN, Onerci M, Turan E. Peristomal recurrence. Am J Otolaryngol 1993;14:206-8.
11. Baluyot ST Jr, Shumrick DA, Everts EC. "Emergency" laryngectomy. Arch Otolaryngol 1971;94:414-7.
12. Modlin B, Ogura JH. Post-laryngectomy tracheal stomal recurrences. Laryngoscope 1969;79:239-50.
13. Esteban F, Moreno JA, Delgado-Rodrìguez M, Mochon A. Risk factors involved in stomal recurrence following laryngectomy. J Laryngol Otol 1993;107:527-31.
14. Stell PM, van den Broek P. Stomal recurrence after laryngectomy: aetiology and management. J Laryngol Otol 1971;85:131-40.
15. Sisson GA, Bytell DE, Edison BD, Yeh S Jr. Transsternal radical neck dissection for control of stomal recurrences - end results. Laryngoscope 1975;85:1504-10.
16. Schneider JJ, Lindberg RD, Jesse RH. Prevention of tracheal stoma recurrences after total laryngectomy by postoperative irradiation. J Surg Oncol 1975;7:187-90.
17. Tong D, Moss WT, Stevens KR Jr. Elective irradiation of the lower cervical region in patients at high risk for recurrent cancer at the tracheal stoma. Radiology 1977;124:809-11.
18. Weisman RA, Colman M, Ward PH. Stomal recurrence following laryngectomy: a critical evaluation. Ann Otol Rhinol Laryngol 1979;88:855-60.
19. Griebie MS, Adams GL. "Emergency" laryngectomy and stomal recurrence. Laryngoscope 1987;97:1020-4.
20. Zhang L, Epstein J, Band P, et al. Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med 1999;28:381-4.
21. van Oijen MGCT, Leppers Vd Straat FGJ, Tilanus MGJ, Slootweg PJ. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 2000;88:884-93.
22. Parsons R, Li GM, Longley M, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995;268:738-40.
23. Kumar-Singh R, Wang H, Humphries P, Farrar GJ. Autosomal dominant retinitis pigmentosa: no evidence for nonallelic genetic heterogeneity on 3q. Am J Hum Genet 1993;52:319-26.
24. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
25. Gyapay G, Morrisette J, Vignal A, et al. The 1993-94 Genethon human genetic linkage map. Nat Genet 1994;7:246-339.
26. Gonzalez-Zulueta M, Ruppert JM, Tokino K, et al. Microsatellite instability in bladder cancer. Cancer Res 1993;53:5620-3.
27. Weissenbach J, Gyapay G, Dib C, et al. A second-generation linkage map of the human genome. Nature 1992;359:794-801.
28. Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994;70:813-8.
29. Weber JL, Kwitek AE, May PE. Dinucleotide repeat polymorphisms at the D16S260, D16S261, D16S265, D16S266, and D16S267 loci. Nucleic Acids Res 1990;18:4034.
30. Weber JL, Kwitek AE, May PE, Wallace MR, Collins FS, Ledbetter DH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 1990;18:4640.
31. Talbot CC Jr, Avramopoulos D, Gerken S, et al. The tetranucleotide repeat polymorphism D21S1245 demonstrates hypermutability in germline and somatic cells. Hum Mol Genet 1995;4:1193-9.
32. Dockhorn-Dworniczak B, Dworniczak B, Brommelkamp L, Bulles J, Horst J, Bocker WW. Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res 1991;19:2500.
33. Harris AH, Smith RR. Operative wound seeding with tumor cells: its role in recurrences of head and neck cancer. Ann Surg 1960;151:330-4.
34. Rockley TJ, Powell J, Robin PE, Reid AP. Post-laryngectomy stomal recurrence: tumour implantation or paratracheal lymphatic metastasis? Clin Otolaryngol 1991;16:43-7.
35. Welsh LW. The normal human laryngeal lymphatics. Ann Otol Rhinol Laryngol 1964;73:569-82.
36. Shaha AR, Shah JP. Carcinoma of the subglottic larynx. Am J Surg 1982;144:456-8.
37. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985;56:1242-5.
38. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7.
39. Franco EL, Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol 1991;44:615-25.
40. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol 1997;33:332-7.
41. El Naggar AK, Hurr K, Huff V, Clayman GL, Luna MA, Batsakis JG. Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am J Pathol 1996;148:2067-72.
42. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-83.